Cellosaurus cell line PC-6/TAX1-1 (CVCL

Cellosaurus PC-6/TAX1-1 (CVCL_S849)

Cross-references
Cell line name	PC-6/TAX1-1
Synonyms	PC-6/Tax1-1
Accession	CVCL_S849
Resource Identification Initiative	To cite this cell line use: PC-6/TAX1-1 (RRID:CVCL_S849)
Comments	Population: Japanese. Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
Disease	Lung small cell carcinoma (NCIt: C4917) Small cell lung cancer (ORDO: Orphanet_70573)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy	Parent: CVCL_C002 (PC-6)
Sex of cell	Sex unspecified
Age at sampling	Age unspecified
Category	Cancer cell line
Publications	PubMed=10912951; DOI=10.1097/00001813-200006000-00005 Ishii M., Iwahana M., Mitsui I., Minami M., Imagawa S., Tohgo A., Ejima A. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6. Anticancer Drugs 11:353-362(2000) PubMed=17237272; DOI=10.1158/1535-7163.MCT-06-0529 Oguri T., Bessho Y., Achiwa H., Ozasa H., Maeno K., Maeda H., Sato S., Ueda R. MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol. Cancer Ther. 6:122-127(2007) PubMed=18445659; DOI=10.1158/1535-7163.MCT-07-2088 Oguri T., Ozasa H., Uemura T., Bessho Y., Miyazaki M., Maeno K., Maeda H., Sato S., Ueda R. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer. Mol. Cancer Ther. 7:1150-1155(2008)
Encyclopedic resources	Wikidata; Q54938463
Entry history
Entry creation	03-Feb-2014
Last entry update	19-Dec-2024
Version number	9